Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
May 22, 2021
Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof-of-concept study
Shitanshu Uppal, Erin Medlin, Mildred Felder, et al.
Radiology
|
February 27, 2018
Indeterminate Adnexal Cysts at US: Prevalence and Characteristics of Ovarian Cancer
Elizabeth A Sadowski, Viktoriya Paroder, Krupa Patel-Lippmann, et al.
Scientific Reports
|
January 20, 2018
Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin
Arvinder Kapur, Thomas Beres, Kavya Rathi, et al.
AJR. American Journal of Roentgenology
|
November 27, 2019
Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts
Krupa K Patel-Lippmann, Elizabeth A Sadowski, Jessica B Robbins, et al.
Cancer Research Communications
|
December 4, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression
Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer
Britt K Erickson, Howard Bailey, Rebecca C Arend, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery
Tracy M Downs, Howard H Bailey, Taja Lozar, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
JCI Insight
|
April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma
Usha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
May 22, 2021
Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof-of-concept study
Shitanshu Uppal, Erin Medlin, Mildred Felder, et al.
Radiology
|
February 27, 2018
Indeterminate Adnexal Cysts at US: Prevalence and Characteristics of Ovarian Cancer
Elizabeth A Sadowski, Viktoriya Paroder, Krupa Patel-Lippmann, et al.
Scientific Reports
|
January 20, 2018
Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin
Arvinder Kapur, Thomas Beres, Kavya Rathi, et al.
AJR. American Journal of Roentgenology
|
November 27, 2019
Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts
Krupa K Patel-Lippmann, Elizabeth A Sadowski, Jessica B Robbins, et al.
Cancer Research Communications
|
December 4, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression
Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer
Britt K Erickson, Howard Bailey, Rebecca C Arend, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery
Tracy M Downs, Howard H Bailey, Taja Lozar, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
JCI Insight
|
April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma
Usha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Page
of 6